Home » Health » Semaglutide: The Groundbreaking Weight-loss Drug That Reduces Cardiovascular Disease Risk

Semaglutide: The Groundbreaking Weight-loss Drug That Reduces Cardiovascular Disease Risk

by Alexandra Hartman Editor-in-Chief

2023-11-16 06:31:19

Al-Marsad newspaper: An international team of scientists discovered that the famous weight-loss drug semaglutide can reduce the risk of cardiovascular disease.

According to the New England Journal of Medicine, the aforementioned drug can reduce the risk of cardiovascular diseases, including myocardial infarction and stroke, in obese people by 20 percent.

It is noteworthy that semaglutide was originally prescribed for people with type 2 diabetes, but its use has recently increased in weight loss in adults who suffer from overweight and at least one other health problem.

1700129776
#Discovery #common #weightloss #drug #reduces #incidence #heart #disease #AlMarsad #newspaper

You may also like

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Adblock Detected

Please support us by disabling your AdBlocker extension from your browsers for our website.